Substance / Medication

Metoprolol

Overview

Active Ingredient
metoprolol
RxNorm CUI
6918

Indications & Related Conditions

Conditions associated via SNOMED clinical relationships

Administration & Protocol

Dosing, route, and treatment protocol

Administration details including route, dosing schedules, preparation instructions, and contraindications are pending physician authorship.

Monitoring & Follow-Up

Biomarkers relevant to this intervention via related conditions

Clinical Trials

12 trials linked to this intervention

12
Total Trials
1
Recruiting
4
With Results

Research Evidence

Published studies and systematic reviews

Sort:
Metoprolol vs diltiazem for atrial fibrillation with rapid ventricular rate: Systematic review and meta-analysis of adverse events.
Hintze Trager D, Downing Jessica V, Acquisto Nicole M et al. · Am J Emerg Med · 2025
PMID: 39764905Meta-Analysis
Which should you choose for post operative atrial fibrillation, carvedilol or metoprolol? A systemic review and meta-analysis.
Abouzid Mohamad Riad, Vyas Ankit, Eldahtoury Samar et al. · Curr Probl Cardiol · 2024
PMID: 37989396Meta-Analysis
Clinical Pharmacokinetics of Metoprolol: A Systematic Review.
Zamir Ammara, Hussain Iltaf, Ur Rehman Anees et al. · Clin Pharmacokinet · 2022
PMID: 35764772Meta-Analysis
Intravenous diltiazem versus metoprolol for atrial fibrillation with rapid ventricular rate: A meta-analysis.
Lan Qingsu, Wu Fengchao, Han Bing et al. · Am J Emerg Med · 2022
PMID: 34781150Meta-Analysis
A meta-analysis of wenxin granule and metoprolol for the treatment of coronary heart disease and arrhythmia.
Meng Ling-Li, Huang Wei · Medicine (Baltimore) · 2022
PMID: 36107542Meta-AnalysisFull text (PMC)
CYP2D6 polymorphism and its impact on the clinical response to metoprolol: A systematic review and meta-analysis.
Meloche Maxime, Khazaka Michael, Kassem Imad et al. · Br J Clin Pharmacol · 2020
PMID: 32090368Meta-AnalysisFull text (PMC)

Research data from MEDLINE/PubMed

Benefits & Expected Outcomes

Benefits, expected outcomes, efficacy data, and NNT (Number Needed to Treat) are pending physician authorship and evidence review.

Risks & Side Effects

Risk profile, common and serious adverse effects, contraindications, and drug interactions are pending physician authorship.

Related Symptoms

Symptoms associated with conditions this intervention addresses

No related symptoms have been mapped yet. Symptom linkages are derived through associated conditions.

Alternatives & Comparisons

Alternative treatments, comparison data, and clinical decision support are pending physician authorship.

Medical Disclaimer

This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.

Do not start, stop, or change any treatment without consulting your healthcare provider.

Health Goals

Goals connected through associated conditions

Quick Facts

Type
Substance / Medication
Fully Specified Name
Metoprolol (substance)
SNOMED CT
372826007
UMLS CUI
C0025859
RxNorm CUI
6918

Clinical Data

This intervention maps to 23 entities in the Healos knowledge graph.

9
Conditions
8
Biomarkers
4
Specialists
0
Symptoms
12
Clinical Trials

Data is sourced from SNOMED CT, UMLS, and the Healos clinical knowledge graph. Content sections marked as pending require physician authorship. Consult a healthcare provider before starting any treatment.